Key facts
- It has raised $5.0M; the latest was Early Stage VC ($5.0M) in Jul 2025.
- Notable investors include Innovation Authority, Pitango Venture Capital.
- Status: Privately Held (backing).
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for LeaFix Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for LeaFix Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About LeaFix Medical
Developer of heart valve repair tools intended for treating problems with the mitral valve. The company offers a small implant and a device to place it, which supports the front part of the mitral valve by making it larger and helping it close more effectively. This enables heart doctors to repair valve issues in a less invasive manner for patients who have a mostly normal valve structure.
- Sector
- Healthcare
- HQ
- Givat Brener, Israel
- Founded
- 2025
- Website
- leafix-medical.com/
- Ownership
- Privately Held (backing)
LeaFix Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in LeaFix Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on LeaFix Medical in its N-PORT filings yet. We sweep new filings monthly.